Literature DB >> 22416745

To tell the truth, the whole truth, may do patients harm: the problem of the nocebo effect for informed consent.

Rebecca Erwin Wells1, Ted J Kaptchuk.   

Abstract

The principle of informed consent obligates physicians to explain possible side effects when prescribing medications. This disclosure may itself induce adverse effects through expectancy mechanisms known as nocebo effects, contradicting the principle of nonmaleficence. Rigorous research suggests that providing patients with a detailed enumeration of every possible adverse event-especially subjective self-appraised symptoms-can actually increase side effects. Describing one version of what might happen (clinical "facts") may actually create outcomes that are different from what would have happened without this information (another version of "facts"). This essay argues that the perceived tension between balancing informed consent with nonmaleficence might be resolved by recognizing that adverse effects have no clear black or white "truth." This essay suggests a pragmatic approach for providers to minimize nocebo responses while still maintaining patient autonomy through "contextualized informed consent," which takes into account possible side effects, the patient being treated, and the particular diagnosis involved.

Entities:  

Mesh:

Year:  2012        PMID: 22416745      PMCID: PMC3352765          DOI: 10.1080/15265161.2011.652798

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  42 in total

1.  Ethics needs principles--four can encompass the rest--and respect for autonomy should be "first among equals".

Authors:  R Gillon
Journal:  J Med Ethics       Date:  2003-10       Impact factor: 2.903

2.  Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches.

Authors:  Dimos D Mitsikostas; Leonidas I Mantonakis; Nikolaos G Chalarakis
Journal:  Cephalalgia       Date:  2011-01-07       Impact factor: 6.292

3.  Mass psychogenic illness attributed to toxic exposure at a high school.

Authors:  T F Jones; A S Craig; D Hoy; E W Gunter; D L Ashley; D B Barr; J W Brock; W Schaffner
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

4.  Placebo expectations and the detection of somatic information.

Authors:  Andrew L Geers; Justin A Wellman; Stephanie L Fowler; Heather M Rasinski; Suzanne G Helfer
Journal:  J Behav Med       Date:  2010-11-03

5.  The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment.

Authors:  Franklin G Miller; Luana Colloca
Journal:  Theor Med Bioeth       Date:  2011-08

Review 6.  Nonspecific medication side effects and the nocebo phenomenon.

Authors:  Arthur J Barsky; Ralph Saintfort; Malcolm P Rogers; Jonathan F Borus
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

7.  Assessing general side effects in clinical trials: reference data from the general population.

Authors:  Winfried Rief; Arthur J Barsky; Julia A Glombiewski; Yvonne Nestoriuc; Heide Glaesmer; Elmar Braehler
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11-08       Impact factor: 2.890

8.  Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients.

Authors:  Simon J C Davies; Peter R Jackson; Lawrence E Ramsay; Parviz Ghahramani
Journal:  Arch Intern Med       Date:  2003-03-10

9.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

10.  Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo.

Authors:  Antonello Silvestri; Pasquale Galetta; Elena Cerquetani; Giuseppe Marazzi; Roberto Patrizi; Massimo Fini; Giuseppe M C Rosano
Journal:  Eur Heart J       Date:  2003-11       Impact factor: 29.983

View more
  68 in total

1.  An audit of the knowledge and attitudes of doctors towards Surgical Informed Consent (SIC).

Authors:  Bushra Ashraf; Nasira Tasnim; Muhammad Saaiq; Khaleeq-Uz- Zaman
Journal:  Int J Health Policy Manag       Date:  2014-10-27

2.  Adverse events during placebo vs. no drug administration--results of a randomised interventional trial in 160 volunteers.

Authors:  Frank Erbguth; Angelika Hamacher-Erbguth; Uwe Fuhr; Fritz Sörgel
Journal:  Eur J Clin Pharmacol       Date:  2015-08-14       Impact factor: 2.953

3.  Placebo improves pleasure and pain through opposite modulation of sensory processing.

Authors:  Dan-Mikael Ellingsen; Johan Wessberg; Marie Eikemo; Jaquette Liljencrantz; Tor Endestad; Håkan Olausson; Siri Leknes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

Review 4.  Pain and the context.

Authors:  Elisa Carlino; Elisa Frisaldi; Fabrizio Benedetti
Journal:  Nat Rev Rheumatol       Date:  2014-02-25       Impact factor: 20.543

5.  Informed consent and clinical trials: where is the placebo effect?

Authors:  C R Blease; F L Bishop; T J Kaptchuk
Journal:  BMJ       Date:  2017-02-03

6.  Potential negative impact of informing patients about medication side effects: a systematic review.

Authors:  Jimmy Jose; Lamia AlHajri
Journal:  Int J Clin Pharm       Date:  2018-08-23

Review 7.  Disease progression and neuroscience.

Authors:  Nick Holford
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-17       Impact factor: 2.745

8.  Harnessing the placebo effect: Exploring the influence of physician characteristics on placebo response.

Authors:  Lauren C Howe; J Parker Goyer; Alia J Crum
Journal:  Health Psychol       Date:  2017-03-09       Impact factor: 4.267

9.  Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Christopher Ma; Nicola R Panaccione; Tran M Nguyen; Leonardo Guizzetti; Claire E Parker; Isra M Hussein; Niels Vande Casteele; Reena Khanna; Parambir S Dulai; Siddharth Singh; Brian G Feagan; Vipul Jairath
Journal:  J Crohns Colitis       Date:  2019-09-19       Impact factor: 9.071

10.  The imagined itch: brain circuitry supporting nocebo-induced itch in atopic dermatitis patients.

Authors:  V Napadow; A Li; M L Loggia; J Kim; I Mawla; G Desbordes; P C Schalock; E A Lerner; T N Tran; J Ring; B R Rosen; T J Kaptchuk; F Pfab
Journal:  Allergy       Date:  2015-09-10       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.